Olin Q4 Sales Flat at $1.67B, EBITDA Down 65% as Price Target Rises to $26
Olin Corporation reported flat Q4 sales at $1.67 billion with its Chlor Alkali segment down 10% YoY, adjusted EBITDA plunged 65% to $67.7 million, and net loss widened to $85.7 million ($0.75/share) versus $10.7 million income a year ago. Deutsche Bank lifted its price target to $26 while peers cut theirs to $21–$24.
1. Q4 Financial Results
Olin reported Q4 2025 sales of $1.67 billion, unchanged year-over-year, while Chlor Alkali Products and Vinyls revenue fell 10%. Adjusted EBITDA dropped 65% to $67.7 million and the net loss widened to $85.7 million, or $0.75 per share, compared with a $10.7 million profit a year earlier.
2. Analyst Reactions and Price Targets
Following the weaker results and softer 2026 guidance, Deutsche Bank raised its target from $23 to $26 and maintained a Hold rating. BMO Capital marginally lowered its target to $24, while Citi and RBC Capital cut theirs to $21, reflecting cautious sentiment.
3. Outlook and Cost Initiatives
Olin expects first-quarter adjusted EBITDA below Q4 levels due to persistent cost pressures and market headwinds. The company generated $321.2 million of operating cash flow in Q4 and achieved $44 million of structural cost savings under its Beyond250 initiative, keeping net debt near year-end 2024 levels.